Anti-glomerular Basement Membrane Disease: What Have We Learned?
- PMID: 32991349
- DOI: 10.1097/PAP.0000000000000280
Anti-glomerular Basement Membrane Disease: What Have We Learned?
Abstract
Since the first clinicopathologic description by Ernest Goodpasture of a patient whom he considered to have died of influenza in 1919, substantial progress has been made in our knowledge of anti-glomerular basement membrane disease. This has led to a significant decrease in the morbidity and mortality associated with this disease. In this paper, we aim to review the literature that has enhanced our understanding of classic anti-glomerular basement membrane disease and its clinic-pathologic variants in the key areas of immunopathogenesis and histopathology. We also summarize varied clinical presentations and therapeutic strategies.
References
-
- McAdoo SP, Pusey CD. Anti-glomerular basement membrane disease. Clin J Am Soc Nephrol. 2017;12:1162–1172.
-
- Gulati K, McAdoo SP. Anti-glomerular basement membrane disease. Rheum Dis Clin North Am. 2018;44:651–673.
-
- Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1–11.
-
- Goodpasture E. The significance of certain pulmonary lesions in relation to the etiology of influenza. Am J Med Sci. 1919;158:863–870.
-
- Parkin TW, Rusted IE, Burchell HB, et al. Hemorrhagic and interstitial pneumonitis with nephritis. Am J Med. 1955;18:220–236.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources